优泌乐50与优泌乐25降餐后血糖临床分析.docVIP

优泌乐50与优泌乐25降餐后血糖的临床分析 　　【摘要】 目的 观察优泌乐50与优泌乐25治疗糖尿病降低餐后血糖水平的临床效果。方法 选取63例糖尿病患者， 随机分为实验组（32例）和对照组（31例）。两组患者均予以常规饮食治疗和健康教育， 在此基础上观察组给予优泌乐50餐前皮下注射， 对照组给予优泌乐25餐前皮下注射， 连续1周记录两组患者注射优泌乐后餐后血糖的变化情况， 分析比较优泌乐50与优泌乐25降低餐后血糖的临床效果。 结果 两组患者治疗1周后的空腹血糖水平均降低， 但差异无统计学意义（P0.05）， 治疗后两组患者的日常三餐的餐后2 h血糖水平也均降低， 观察组患者餐后血糖水平明显低于对照组， 差异具有统计学意义（ P0.05）。 结论 优泌乐50降低餐后血糖水平的效果明显较优泌乐25优越。 　　【关键词】 糖尿病；优泌乐50；优泌乐25；餐后血糖 　　DOI：10.14163/j.cnki.11-5547/r.2015.22.014 　　Clinical analysis of Humalog 50 and Humalog 25 for regulating postprandial blood glucose LI Lan-sheng. Nanjing City Pukou District Puchang Hospital， Nanjing 210031， China 　　【Abstract】 Objective To observe clinical effect of Humalog 50 and Humalog 25 for treating diabetes mellitus and regulating postprandial blood glucose. Methods A total of 63 diabetes mellitus patients were randomly divided into experimental group （32 cases） and control group （31 cases）. Both groups received conventional dietary therapy and health education. The observation group received additional Humalog 50 by preprandial subcutaneous injection， and the control group received Humalog 25 by preprandial subcutaneous injection. Changes of postprandial blood glucose after injection of Humalog were recorded for 1 week in the two groups. Results Both groups had decreased fasting blood glucose after 1 week of treatment， but their difference had no statistical significance （P0.05）. They also had decreased 2 h postprandial blood glucose after daily meals. The observation group had much lower level of postprandial blood glucose than the control group， and their difference had statistical significance （P0.05）. Conclusion Humalog 50 provides remarkably better effect in regulating postprandial blood glucose than Humalog 25. 　　【Key words】 Diabetes mellitus； Humalog 50； Humalog 25； Postprandial blood glucose 　　糖尿病是目前危害人类健康三大慢性疾病的其中之一， 随着生活水平的提高和环境因素的改变， 糖尿病的发病率逐年提高。糖尿病的治疗在于控制血糖水平预防并发症的发生， 使用药物治疗糖尿病的同时患者应保持健康的低糖低脂饮食和适当的体育活动锻炼[1， 2]。目前国际上糖尿病治疗的主要手段是胰岛素治疗， 其可有效控制血糖、减少糖尿病并发症的发生和发展，